"Dihematoporphyrin Ether" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.
| Descriptor ID |
D017323
|
| MeSH Number(s) |
D03.383.129.578.840.500.462.400.200 D03.633.400.909.500.462.400.200 D04.345.783.500.462.400.200 D23.767.727.462.400.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dihematoporphyrin Ether".
Below are MeSH descriptors whose meaning is more specific than "Dihematoporphyrin Ether".
This graph shows the total number of publications written about "Dihematoporphyrin Ether" by people in this website by year, and whether "Dihematoporphyrin Ether" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dihematoporphyrin Ether" by people in Profiles.
-
Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo. PLoS One. 2013; 8(2):e55652.
-
Cranial neuropathies after intracranial Photofrin-photodynamic therapy for malignant supratentorial gliomas-a report on 3 cases. Surg Neurol. 2008 Aug; 70(2):190-3.
-
1H magnetic resonance imaging of normal brain tissue response to photodynamic therapy. Neurosurgery. 1991 Oct; 29(4):538-46.